Analyst: Weakness In Spark Therapeutics Is Overdone By: Benzinga via Benzinga December 11, 2017 at 13:54 PM EST Spark Therapeutics Inc (NASDAQ: ONCE) reported during the ASH conference an update concerning its SPK-8011 therapy, which has many ... Read More >> Related Stocks: Ashland Inc Spark Therap